Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. disease detection
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Disease Detection Articles & Analysis

167 news found

The Role of Laser Therapy and Advanced Diagnostics in Modern Clinical Medicine

The Role of Laser Therapy and Advanced Diagnostics in Modern Clinical Medicine

In diagnostics, the use of antigen rapid test kits and in vitro diagnostic hematology is accelerating early disease detection, improving treatment outcomes. Meanwhile, supragingival scaling techniques are advancing dental care, while central medical gas systems are ensuring optimal clinical environments. ...

ByContent Management Test Company


Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

Building on our previous promising results in detecting CTCs in EBC, this study aims to further explore these biomarkers' potential in monitoring disease progression and guiding treatment ...

ByTethis S.p.A


Tempus Announces the Clinical Launch of its MRD Testing Portfolio

Tempus Announces the Clinical Launch of its MRD Testing Portfolio

Tempus, a leader in artificial intelligence and precision medicine, today announced the clinical launch of its minimal residual disease (MRD) test portfolio, including Tempus’ xM test and the xM (NeXT Personal® Dx) test by Personalis. The portfolio features both a tumor-naïve assay and a tumor-informed assay that are designed to help detect ...

ByTempus


AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)

AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)

These include screening for trillions of drug compounds to advance medicine, gathering better patient data to aid early disease detection and implementing smarter digital assistants. "For the first time in history, we can represent the world of biology and chemistry in a computer, making computer-aided drug discovery possible," said Kimberly Powell, Vice ...

ByInvestorideas.com


Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study

Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study

Boston: Microneedle technology, driven by high demand in dermatologic procedures and its versatile applications in drug delivery, vaccine administration, and disease diagnostics, faces challenges in its complex manufacturing process. Ongoing research and numerous products in development make this market dynamic for newcomers entering the field. “According to the latest BCC Research study, ...

ByBCC Research


Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. To facilitate efforts on IVD research, the US-based chemical supplier Alfa Chemistry has recently introduced three IVD products for laboratory use, adding to its already diverse range of biological reagents. ...

ByAlfa Chemistry


CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service

CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service

The service provides a comprehensive overview of all viral genetic material present in a sample, enabling the detection of both known and previously unknown viruses in a single assay. ...

ByCD Genomics


Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials

Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials

Some of them are listed below: dotap chloride, transfectam, dlin-kc2-dma, peg2000-c-dmg, dc-cholesterol, 12-o-dioctadecyl-sn-glycerol, 12-dioleoyl-sn-glycero-3-succinate, cardiolipin series, heptaethylene glycol monomethyl ether, methoxy PEG ditetradecylamino, etc . SARS-CoV-2 Detection Raw MaterialsIn response to the demand for accurate and early detection of ...

ByAlfa Chemistry


CD Genomics Unveils Advanced Mitochondrial Diseases Panel Sequencing Service

CD Genomics Unveils Advanced Mitochondrial Diseases Panel Sequencing Service

CD Genomics, a leading biotechnology company specializing in genomics and sequencing, has announced the launch of its advanced Mitochondrial Diseases Panel Sequencing services. This new panel enables rapid and accurate detection of mutations in mitochondrial DNA (mtDNA) that are associated with a wide range of mitochondrial disorders. ...

ByCD Genomics


CD Genomics Longseq Division Unveils Human Leukocyte Antigen (HLA) Typing Service

CD Genomics Longseq Division Unveils Human Leukocyte Antigen (HLA) Typing Service

HLA regions are associated with the greatest number of human diseases in the human genome, and HLA typing is particularly important for assessing immune compatibility between organ donor and recipient pairs. There are more than 100 kinds of diseases related to HLA, involving autoimmune diseases, immunodeficiency diseases, ...

ByCD Genomics


Lifespin Announces Expansion of Laboratory Testing Capability

Lifespin Announces Expansion of Laboratory Testing Capability

” Lifespin is working to build new precision medicine tools based on quantitative metabolic profiles and proprietary algorithms to assist in the early detection of diseases and monitoring the efficacy of health treatments. To facilitate these services, the company has established one of the largest and most comprehensive databases of metabolic health ...

ByLifespin GmbH


Bayer completes acquisition of Blackford Analysis Ltd.

Bayer completes acquisition of Blackford Analysis Ltd.

“Bayer is a leader in key radiology areas with a comprehensive portfolio and a deep medical understanding across a multitude of diseases. We are excited that we are now able to join forces with the exceptional Blackford team to use our combined expertise for the benefit of patients and their treating ...

ByBayer AG


Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

Aging populations and changing lifestyles are leading to an increase in chronic conditions, such as cardiovascular disease and cancer. Consequently, the demand for medical imaging to detect diseases, guide treatment decisions and support therapy planning is growing. ...

ByBayer AG


Built In Honors Iterative Health in Its Esteemed 2023 Best Places To Work Awards

Built In Honors Iterative Health in Its Esteemed 2023 Best Places To Work Awards

About Iterative Health Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the accuracy of colorectal cancer screenings. ...

ByIterative Health, Inc.


HEDIS OSW Helps Osteoporosis Patients and Early Detection

HEDIS OSW Helps Osteoporosis Patients and Early Detection

Osteoporosis is a disorder that causes the bone density to reduce with time, making bones so weak they get fractured even with a light fall. Regular testing has many benefits as it is tracked by HEDIS (Healthcare Effectiveness Data and Information) to ensure early detection among women to manage their condition properly. Read on to know ...

ByBeamMed Inc.


Iterative Health Partners with Gastro Health to Accelerate Clinical Research in Gastroenterology Through Artificial Intelligence

Iterative Health Partners with Gastro Health to Accelerate Clinical Research in Gastroenterology Through Artificial Intelligence

This strategic partnership will lay the groundwork for future collaborations by using AIR to aid in the recruitment of patients for clinical trials in inflammatory bowel disease (IBD) and expanding Gastro Health’s clinical research capabilities. ...

ByIterative Health, Inc.


Digital Diagnostics Named to the 2022 CB Insights’ Digital Health 150 List

Digital Diagnostics Named to the 2022 CB Insights’ Digital Health 150 List

IDx-DR, Digital Diagnostics’ flagship product, detects more than mild diabetic retinopathy (including macular edema) at the point-of-care proving a diagnosis when disease is present. After completing a rigorous prospective, preregistered clinical trial at primary care sites across the country, IDx-DR became the first FDA De Novo cleared fully autonomous AI ...

ByDigital Diagnostics Inc.


Iterative Health Named to the 2022 CB Insights’ Digital Health 150 List

Iterative Health Named to the 2022 CB Insights’ Digital Health 150 List

About Iterative Health Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the accuracy of colorectal cancer screenings. ...

ByIterative Health, Inc.


Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

(NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the results of four clinical studies presented at the American Heart Association’s (AHA) 2022 Scientific Sessions in Chicago, IL. ...

ByZio by iRhythm Technologies, Inc.


New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective

New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective

(NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and prevent disease, today announced a new health economic analysis of the mSToPS study, presented at the American Heart Association’s 2022 Scientific Sessions event. ...

ByZio by iRhythm Technologies, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT